Infectious complications of biological and small molecule targeted immunomodulatory therapies

JS Davis, D Ferreira, E Paige, C Gedye… - Clinical microbiology …, 2020 - Am Soc Microbiol
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …
被引用次数：102 相关文章
[HTML] nih.gov

[HTML][HTML] Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies

JS Davis, D Ferreira, E Paige, C Gedye… - Clinical Microbiology …, 2020 - ncbi.nlm.nih.gov
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies

JS Davis, D Ferreira, E Paige… - Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

JS Davis, D Ferreira, E Paige, C Gedye… - Clinical Microbiology …, 2020 - europepmc.org
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies

JS Davis, D Ferreira, E Paige… - Clinical Microbiology …, 2020 - researchers.cdu.edu.au
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Infectious complications of biological and small molecule targeted immunomodulatory therapies.

JS Davis, D Ferreira, E Paige, C Gedye, M Boyle - 2020 - cabidigitallibrary.org
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …

Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies

JS Davis, D Ferreira, E Paige… - Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
The past 2 decades have seen a revolution in our approach to therapeutic
immunosuppression. We have moved from relying on broadly active traditional medications …